Cohen Klingenstein LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cohen Klingenstein LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$611,160
+0.9%
6,0000.0%0.03%
+7.7%
Q2 2023$605,460
+9.7%
6,0000.0%0.03%0.0%
Q1 2023$552,000
+1.4%
6,0000.0%0.03%
-3.7%
Q4 2022$544,320
+19.4%
6,0000.0%0.03%
+12.5%
Q3 2022$456,000
-10.1%
6,0000.0%0.02%
-4.0%
Q2 2022$507,000
-3.8%
6,0000.0%0.02%
+13.6%
Q1 2022$527,000
+0.4%
6,0000.0%0.02%
+4.8%
Q4 2021$525,000
+6.9%
6,0000.0%0.02%0.0%
Q3 2021$491,000
-10.2%
6,0000.0%0.02%
-12.5%
Q2 2021$547,000
+6.6%
6,0000.0%0.02%0.0%
Q1 2021$513,000
-9.5%
6,0000.0%0.02%
-14.3%
Q4 2020$567,000
+8.6%
6,0000.0%0.03%
-3.4%
Q3 2020$522,000
-0.4%
6,0000.0%0.03%
-9.4%
Q2 2020$524,000
+5.9%
6,0000.0%0.03%
-13.5%
Q1 2020$495,000
-12.9%
6,0000.0%0.04%
+12.1%
Q4 2019$568,000
+9.0%
6,0000.0%0.03%0.0%
Q3 2019$521,000
-4.9%
6,0000.0%0.03%
-15.4%
Q2 2019$548,000
-5.0%
6,0000.0%0.04%
-2.5%
Q1 2019$577,000
+12.0%
6,0000.0%0.04%
-48.7%
Q4 2018$515,000
-0.4%
6,0000.0%0.08%
+18.2%
Q3 2018$517,000
+14.1%
6,0000.0%0.07%
+6.5%
Q2 2018$453,000
-6.6%
6,0000.0%0.06%
-10.1%
Q1 2018$485,000
-3.8%
6,0000.0%0.07%
-4.2%
Q4 2017$504,000
-2.1%
6,0000.0%0.07%
-7.7%
Q3 2017$515,000
+2.8%
6,0000.0%0.08%0.0%
Q2 2017$501,000
+12.3%
6,0000.0%0.08%
+9.9%
Q1 2017$446,000
+2.1%
6,0000.0%0.07%
-5.3%
Q4 2016$437,000
-7.8%
6,0000.0%0.08%
-8.5%
Q3 2016$474,000
-4.2%
6,0000.0%0.08%
-9.9%
Q2 2016$495,000
+13.8%
6,0000.0%0.09%
+11.0%
Q1 2016$435,000
-15.7%
6,0000.0%0.08%
-14.6%
Q4 2015$516,000
-6.5%
6,0000.0%0.10%
-11.9%
Q3 2015$552,000
-6.4%
6,0000.0%0.11%
+2.8%
Q2 2015$590,000
-0.3%
6,0000.0%0.11%
-1.9%
Q1 2015$592,000
+6.5%
6,0000.0%0.11%
+3.8%
Q4 2014$556,000
-1.6%
6,0000.0%0.10%
+4.0%
Q3 2014$565,000
+4.1%
6,0000.0%0.10%
-3.8%
Q2 2014$543,000
+6.5%
6,0000.0%0.10%
+3.0%
Q1 2014$510,000
+5.8%
6,0000.0%0.10%
+5.2%
Q4 2013$482,000
+4.8%
6,0000.0%0.10%
-4.0%
Q3 2013$460,000
+8.5%
6,0000.0%0.10%
+1.0%
Q2 2013$424,0006,0000.10%
Other shareholders
NOVARTIS A G shareholders Q1 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders